Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Body hair isn't a good substitute for scalp hair in steroid analysis.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Alpha-melanocyte-stimulating hormone helps manage skin inflammation and protect against UV damage.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

People who recently attempted suicide during depression showed signs of adrenal fatigue, but had higher DHEA levels around the attempt time.

CRH can cause hair loss by promoting cell death in hair growth cells.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

High doses of some selenium supplements caused liver and reproductive harm in rats.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

More research is needed to understand how testosterone is maintained in adult males.